A Distributed Algorithm for Balanced Hypergraph Partitioning

Wenyin Yang,Guojun Wang,Li Ma,Shiyang Wu

DOI: https://doi.org/10.1007/978-3-319-49178-3_36

2016-11-16

Abstract:

What problem does this paper attempt to address?

Respiratory Syncytial Virus Seasonality, Beijing, China, 2007–2015

Jianxing Yu,Chunyan Liu,Yan Xiao,Zichun Xiang,Hongli Zhou,Lan Chen,Kunling Shen,Zhengde Xie,Lili Ren,Jianwei Wang

DOI: https://doi.org/10.3201/eid2506.180532

IF: 16.126

2019-01-01

Emerging Infectious Diseases

Abstract:During July 2007-June 2015, we enrolled 4,225 hospitalized children with pneumonia in a study to determine the seasonality of respiratory syncytial virus (RSV) infection in Beijing, China. We defined season as the period during which >10% of total PCRs performed each week were RSV positive. We identified 8 distinctive RSV seasons. On average, the season onset occurred at week 41 (mid-October) and lasted 33 weeks, through week 20 of the next year (mid-May); 97% of all RSV-positive cases occurred during the season. RSV seasons occurred 3-5 weeks earlier and lasted ≈6 weeks longer in RSV subgroup A-dominant years than in RSV subgroup B-dominant years. Our analysis indicates that monitoring such RSV subgroup shifts might provide better estimates for the onset of RSV transmission. PCR-based tests could be a flexible or complementary way of determining RSV seasonality in locations where RSV surveillance is less well-established, such as local hospitals throughout China.
A semi-empirical risk panel to monitor epidemics: multi-faceted tool to assist healthcare and public health professionals

Aida Perramon-Malavez,Mario Bravo,Víctor López de Rioja,Martí Català,Sergio Alonso,Enrique Álvarez-Lacalle,Daniel López,Antoni Soriano-Arandes,Clara Prats

DOI: https://doi.org/10.3389/fpubh.2023.1307425

IF: 5.2

2024-01-08

Frontiers in Public Health

Abstract:Introduction Bronchiolitis, mostly caused by Respiratory Syncytial Virus (RSV), and influenza among other respiratory infections, lead to seasonal saturation at healthcare centers in temperate areas. There is no gold standard to characterize the stages of epidemics, nor the risk of respiratory infections growing. We aimed to define a set of indicators to assess the risk level of respiratory viral epidemics, based on both incidence and their short-term dynamics, and considering epidemical thresholds. Methods We used publicly available data on daily cases of influenza for the whole population and bronchiolitis in children <2 years from the Information System for Infection Surveillance in Catalonia (SIVIC). We included a Moving Epidemic Method (MEM) variation to define epidemic threshold and levels. We pre-processed the data with two different nowcasting approaches and performed a 7-day moving average. Weekly incidences (cases per 10 5 population) were computed and the 5-day growth rate was defined to create the effective potential growth (EPG) indicator. We performed a correlation analysis to define the forecasting ability of this index. Results Our adaptation of the MEM method allowed us to define epidemic weekly incidence levels and epidemic thresholds for bronchiolitis and influenza. EPG was able to anticipate daily 7-day cumulative incidence by 4–5 (bronchiolitis) or 6–7 (influenza) days. Discussion We developed a semi-empirical risk panel incorporating the EPG index, which effectively anticipates surpassing epidemic thresholds for bronchiolitis and influenza. This panel could serve as a robust surveillance tool, applicable to respiratory infectious diseases characterized by seasonal epidemics, easy to handle for individuals lacking a mathematical background.

public, environmental & occupational health
Evaluating a novel predictive tool for respiratory infection outbreaks in real life.

Rousogianni,E.,Perlepe,G. e.,Meletis,E.,Rouka,E.,Boutlas,S.,Poulakida,I.,Rapti,G.,Gouta,E.,Mpaltopoulou,E.,Mpaltopoulos,G.,Risdiyanto,R.,Papagiannis,D.,Kostoulas,P.,Gourgoulianis,K. I.

DOI: https://doi.org/10.1183/13993003.congress-2024.pa5110

IF: 24.3

2024-11-01

European Respiratory Journal

Abstract:Introduction: Respiratory infections are a prevalent cause for individuals seeking medical guidance, remaining a public health threat, emphasizing the role of warning tools in managing health threats. Aims and objectives: Estimating Epidemic Volatility Index(EVI) as an early warning tool in real life. Methods: The study, ongoing since October 16th, includes adults presenting in our hospital with respiratory infection symptoms from whom nasal specimens are collected. We documented infections necessitating hospitalization and assessed the proportion attributed to specific viruses. EVI issues early warnings(red dots) on its online platform, illustrating in real time the correlation between successive red dots and the onset of new waves[1]. Results: Among 948 adults tested, positive tests were: 23.52 % Flu-A, 0.11% Flu-B, 18.46 % SARS-CoV-2, 2.43% RSV, 0.74% Adenovirus. 54.75% of total yielded negative test. Hospital admissions were 159(16.77%). Among them, 23.27% for Flu-A, 13.21% for SARS-CoV-2, 3.77% for RSV, 0.63% for Adenovirus. We observed a predominance of diagnosed cases (59.7%) over undiagnosed ones (40.3%) the Flu-A outbreak period(Fig 3). Synthesizing EVI's figures and our results, we illustrate that the model issued a warning 14 days prior to the abrupt increase in Flu-A and SARS-CoV-2 positive cases, indicating the onset of new wave(Fig. 1,2). Conclusions: EVI's timely alerts could aid healthcare systems in preparing for surges ensuring resources and staff availability. Overall, these tools enable rapid response, resource allocation, and international collaboration minimizing health crises impact. 1. Meletis et al, Infect. Public Health 2024 2. Papagiannis et al, Diseases 2023

respiratory system
Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV

Céline Delestrain,Kostas Danis,Isabelle Hau,Sylvie Behillil,Marie‐Noëlle Billard,Leyla Krajten,Robert Cohen,Louis Bont,Ralph Epaud

DOI: https://doi.org/10.1002/ppul.25644

IF: 4.0899

2021-09-02

Pediatric Pulmonology

Abstract:IntroductionCOVID-19 pandemic and associated lockdown measures have deeply modified the natural course of seasonal viral infections, such as respiratory syncytial virus (RSV). MethodsWe analyzed French national data from three networks: emergency departments (ED) of French hospitals, general practitioners (GP), and hospital laboratories. We compared the number of ED or GP visits for bronchiolitis in children <2 years of age, and the percentage of RSV positive tests in the 2020 to 2021 season with those of the two previous seasons (2018–2019 and 2019–2020). We used time series of the previous 5 years to calculate epidemic thresholds. ResultsDuring the 2020–2021 season, the epidemic begun in February (Week 05) in the Ile de France (Paris and suburbs) region, 12 weeks later compared with the previous seasons and progressively spread across all the French metropolitan regions. The highest number of bronchiolitis cases in 2021 (Week 12) occurred 10–12 weeks after the previous seasonal peaks of previous seasons, but the number of cases remained lower than in the previous seasonal peaks. ConclusionWe identified a delayed RSV epidemic in the period that usually corresponds at the end of the epidemic season, raising concerns for the burden of RSV in the already strained healthcare systems during the COVID-19 pandemic.

pediatrics,respiratory system
Integrating information from historical data into mechanistic models for influenza forecasting

Alessio Andronico,Juliette Paireau,Simon Cauchemez

DOI: https://doi.org/10.1371/journal.pcbi.1012523

2024-10-31

PLoS Computational Biology

Abstract:Seasonal influenza causes significant annual morbidity and mortality worldwide. In France, it is estimated that, on average, 2 million individuals consult their GP for influenza-like-illness (ILI) every year. Traditionally, mathematical models used for epidemic forecasting can either include parameters capturing the infection process (mechanistic or compartmental models) or rely on time series analysis approaches that do not make mechanistic assumptions (statistical or phenomenological models). While the latter make extensive use of past epidemic data, mechanistic models are usually independently initialized in each season. As a result, forecasts from such models can contain trajectories that are vastly different from past epidemics. We developed a mechanistic model that takes into account epidemic data from training seasons when producing forecasts. The parameters of the model are estimated via a first particle filter running on the observed data. A second particle filter is then used to produce forecasts compatible with epidemic trajectories from the training set. The model was calibrated and tested on 35 years' worth of surveillance data from the French Sentinelles Network, representing the weekly number of patients consulting for ILI over the period 1985–2019. Our results show that the new method improves upon standard mechanistic approaches. In particular, when retrospectively tested on the available data, our model provides increased accuracy for short-term forecasts (from one to four weeks into the future) and peak timing and intensity. Our new approach for epidemic forecasting allows the integration of key strengths of the statistical approach into the mechanistic modelling framework and represents an attempt to provide accurate forecasts by making full use of the rich surveillance dataset collected in France since 1985. Seasonal influenza causes significant morbidity and mortality worldwide. In France, on average, 2 million individuals consult their GP for influenza-like-illness (ILI) every year. Forecasting the future trajectory of an epidemic in real-time can inform public health responses. Traditionally, two types of mathematical models are used to forecast infectious diseases outbreaks: (1) mechanistic models that explicitly capture transmission mechanisms and (2) statistical models that rely on the similarity between epidemic dynamics over the years. In contrast to statistical models, mechanistic models usually do not use information on past seasons to inform forecasts. This may result in poor performance when forecasted trajectories are very different from past epidemics. Here, we propose a framework that combines these two approaches by allowing mechanistic models to learn from trends observed in past epidemics. We evaluate this approach in the context of seasonal influenza in France. Our results show that the new method improves upon standard mechanistic approaches. In particular, our model provides increased accuracy for predicting the epidemic trajectory one to four weeks into the future, as well as the timing and size of the peak. Our new approach for epidemic forecasting allows combining statistical and mechanistic models to improve forecasts performance.

biochemical research methods,mathematical & computational biology
Exploiting routinely collected severe case data to monitor and predict influenza outbreaks

Alice Corbella,Xu-Sheng Zhang,Paul J. Birrell,Nicki Boddington,Richard G. Pebody,Anne M. Presanis,Daniela De Angelis

DOI: https://doi.org/10.1186/s12889-018-5671-7

IF: 4.5

2018-06-26

BMC Public Health

Abstract:BackgroundInfluenza remains a significant burden on health systems. Effective responses rely on the timely understanding of the magnitude and the evolution of an outbreak. For monitoring purposes, data on severe cases of influenza in England are reported weekly to Public Health England. These data are both readily available and have the potential to provide valuable information to estimate and predict the key transmission features of seasonal and pandemic influenza.MethodsWe propose an epidemic model that links the underlying unobserved influenza transmission process to data on severe influenza cases. Within a Bayesian framework, we infer retrospectively the parameters of the epidemic model for each seasonal outbreak from 2012 to 2015, including: the effective reproduction number; the initial susceptibility; the probability of admission to intensive care given infection; and the effect of school closure on transmission. The model is also implemented in real time to assess whether early forecasting of the number of admissions to intensive care is possible.ResultsOur model of admissions data allows reconstruction of the underlying transmission dynamics revealing: increased transmission during the season 2013/14 and a noticeable effect of the Christmas school holiday on disease spread during seasons 2012/13 and 2014/15. When information on the initial immunity of the population is available, forecasts of the number of admissions to intensive care can be substantially improved.ConclusionReadily available severe case data can be effectively used to estimate epidemiological characteristics and to predict the evolution of an epidemic, crucially allowing real-time monitoring of the transmission and severity of the outbreak.

public, environmental & occupational health
Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April–June 2020)

George Shirreff,Bich-Tram Huynh,Audrey Duval,Lara Cristina Pereira,Djillali Annane,Aurélien Dinh,Olivier Lambotte,Sophie Bulifon,Magali Guichardon,Sebastien Beaune,Julie Toubiana,Elsa Kermorvant-Duchemin,Gerard Chéron,Hugues Cordel,Laurent Argaud,Marion Douplat,Paul Abraham,Karim Tazarourte,Géraldine Martin-Gaujard,Philippe Vanhems,Delphine Hilliquin,Duc Nguyen,Guillaume Chelius,Antoine Fraboulet,Laura Temime,Lulla Opatowski,Didier Guillemot,EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling

DOI: https://doi.org/10.1038/s41598-023-50228-8

IF: 4.6

2024-02-16

Scientific Reports

Abstract:The transmission risk of SARS-CoV-2 within hospitals can exceed that in the general community because of more frequent close proximity interactions (CPIs). However, epidemic risk across wards is still poorly described. We measured CPIs directly using wearable sensors given to all present in a clinical ward over a 36-h period, across 15 wards in three hospitals in April-June 2020. Data were collected from 2114 participants and combined with a simple transmission model describing the arrival of a single index case to the ward to estimate the risk of an outbreak. Estimated epidemic risk ranged four-fold, from 0.12 secondary infections per day in an adult emergency to 0.49 per day in general paediatrics. The risk presented by an index case in a patient varied 20-fold across wards. Using simulation, we assessed the potential impact on outbreak risk of targeting the most connected individuals for prevention. We found that targeting those with the highest cumulative contact hours was most impactful (20% reduction for 5% of the population targeted), and on average resources were better spent targeting patients. This study reveals patterns of interactions between individuals in hospital during a pandemic and opens new routes for research into airborne nosocomial risk.

multidisciplinary sciences
Using a population-based Kalman estimator to model the COVID-19 epidemic in France: estimating associations between disease transmission and non-pharmaceutical interventions

Annabelle Collin,Boris P. Hejblum,Carole Vignals,Laurent Lehot,Rodolphe Thiébaut,Philippe Moireau,Mélanie Prague

DOI: https://doi.org/10.1515/ijb-2022-0087

2023-01-08

The International Journal of Biostatistics

Abstract:In response to the COVID-19 pandemic caused by SARS-CoV-2, governments have adopted a wide range of non-pharmaceutical interventions (NPI). These include stringent measures such as strict lockdowns, closing schools, bars and restaurants, curfews, and barrier gestures such as mask-wearing and social distancing. Deciphering the effectiveness of each NPI is critical to responding to future waves and outbreaks. To this end, we first develop a dynamic model of the French COVID-19 epidemics over a one-year period. We rely on a global extended Susceptible-Infectious-Recovered (SIR) mechanistic model of infection that includes a dynamic transmission rate over time. Multilevel data across French regions are integrated using random effects on the parameters of the mechanistic model, boosting statistical power by multiplying integrated observation series. We estimate the parameters using a new population-based statistical approach based on a Kalman filter, used for the first time in analysing real-world data. We then fit the estimated time-varying transmission rate using a regression model that depends on the NPIs while accounting for vaccination coverage, the occurrence of variants of concern (VoC), and seasonal weather conditions. We show that all NPIs considered have an independent significant association with transmission rates. In addition, we show a strong association between weather conditions that reduces transmission in summer, and we also estimate increased transmissibility of VoC.
Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018

C. Demont,N. Petrica,I. Bardoulat,S. Duret,L. Watier,A. Chosidow,M. Lorrot,A. Kieffer,M. Lemaitre

DOI: https://doi.org/10.1186/s12879-021-06399-8

IF: 3.7

2021-08-02

BMC Infectious Diseases

Abstract:Abstract Background Respiratory syncytial virus (RSV) is the main cause of infant and child hospitalizations. The study objective is to estimate the RSV-associated hospitalizations and economic burden in young children in France to inform future preventive strategies. Methods We conducted a retrospective analysis of RSV-associated hospitalizations data from the French Hospital database (PMSI-MCO) which covers the entire French population. All children aged < 5 years hospitalized with RSV ICD-10 codes (J210, J219, J45, J121, J205, R062) from 2010 to 2018, were included. Descriptive analyses were conducted by RSV seasons (Oct to March), by respiratory years (July to June) and per age groups. Results On average 45,225 RSV-associated hospitalizations (range: 43,715 – 54,616) per season was reported in France, 69% among children < 1 year old. This represents 28% of all-cause hospitalizations that occurred among children < 1 year old, and less than 10% of all-cause hospitalizations in older children. Number of RSV-associated hospitalizations were similar for infants born during (Oct-March) or outside (April–September) their first RSV season. The highest risk being reported for infants born from September through November. The associated hospitalization cost increased between 2010 - 11 and 2017–18, from €93.2 million to €124.1 million, respectively, and infants < 1 year old represented 80% of the economic burden. Conclusion RSV is an important cause of child hospitalization in France. The burden on healthcare system is mainly driven by < 1 year olds, and preventive strategies should be implemented before the first RSV season.

infectious diseases
Assessment of surveillance predictors for suspected respiratory syncytial virus, influenza and Streptococcus pneumoniae infections in children aged <5 years in Madagascar

Norosoa Harline Razanajatovo,Zo Zafitsara Andrianirina,Todisoa Andriatahina,Julia Guillebaud,Aina Harimanana,Elisoa Hariniaina Ratsima,Hervé Rakotoariniaina,Arnaud Orelle,Rila Ratovoson,Judickaelle Irinantenaina,Dina Arinalina Rakotonanahary,Lovasoa Ramparany,Frédérique Randrianirina,Jean-Michel Heraud,Vincent Richard

DOI: https://doi.org/10.1016/j.ijregi.2021.12.003

2021-12-13

Abstract:Background: The lack of rapid, sensitive and affordable diagnostic tests that can distinguish a wide variety of respiratory pathogens at the point of care is an obstacle to the rapid implementation of control measures following events and epidemics. In addition, the absence of a standardized case definition to differentiate putative aetiologies is a challenge to assessing the burden of disease. This study aimed to identify the clinical spectrum of respiratory pathogens commonly associated with respiratory tract infections in the context of disease surveillance. Methods: Data obtained from prospective hospital-based severe acute respiratory infection surveillance among children aged <5 years from November 2010 to July 2013 were used in this study. Results: Intercostal recession and dyspnoea were predictive of respiratory syncytial virus (RSV) infection, whereas headache and chills were more often observed during influenza A infection. Male patients were at a higher risk for RSV infection than female patients. Productive cough, chills, sweating and weight loss were significantly associated with Streptococcus pneumoniae infection. The presence of fever did not necessarily indicate RSV infection. Conclusions: Combined with other examinations, this study shows the value of including the syndromic approach in the panel of diagnostic criteria for rapid identification of the risk of infectious diseases in areas where laboratory diagnostics are challenging. Given the current situation with coronavirus disease 2019, this approach may help decision makers to implement appropriate control measures.
Detecting signals of seasonal influenza severity through age dynamics

Elizabeth C Lee,Cécile Viboud,Lone Simonsen,Farid Khan,Shweta Bansal

DOI: https://doi.org/10.1186/s12879-015-1318-9

2015-12-29

Abstract:Background: Measures of population-level influenza severity are important for public health planning, but estimates are often based on case-fatality and case-hospitalization risks, which require multiple data sources, are prone to surveillance biases, and are typically unavailable in the early stages of an outbreak. To address the limitations of traditional indicators, we propose a novel severity index based on influenza age dynamics estimated from routine physician diagnosis data that can be used retrospectively and for early warning. Methods: We developed a quantitative 'ground truth' severity benchmark that synthesizes multiple traditional severity indicators from publicly available influenza surveillance data in the United States. Observing that the age distribution of cases may signal severity early in an epidemic, we constructed novel retrospective and early warning severity indexes based on the relative risk of influenza-like illness (ILI) among working-age adults to that among school-aged children using weekly outpatient medical claims. We compared our relative risk-based indexes to the composite benchmark and estimated seasonal severity for flu seasons from 2001-02 to 2008-09 at the national and state levels. Results: The severity classifications made by the benchmark were not uniquely captured by any single contributing metric, including pneumonia and influenza mortality; the influenza epidemics of 2003-04 and 2007-08 were correctly identified as the most severe of the study period. The retrospective index was well correlated with the severity benchmark and correctly identified the two most severe seasons. The early warning index performance varied, but it projected 2007-08 as relatively severe 10 weeks prior to the epidemic peak. Influenza severity varied significantly among states within seasons, and four states were identified as possible early warning sentinels for national severity. Conclusions: Differences in age patterns of ILI may be used to characterize seasonal influenza severity in the United States in real-time and in a spatially resolved way. Future research on antigenic changes among circulating viruses, pre-existing immunity, and changing contact patterns may better elucidate the mechanisms underlying these indexes. Researchers and practitioners should consider the use of composite or ILI-based severity metrics in addition to traditional severity measures to inform epidemiological understanding and situational awareness in future seasonal outbreaks.
Real-Time Monitoring of Infectious Disease Outbreaks with a Combination of Google Trends Search Results and the Moving Epidemic Method: A Respiratory Syncytial Virus Case Study

Dawei Wang,Andrea Guerra,Frederick Wittke,John Cameron Lang,Kevin Bakker,Andrew W. Lee,Lyn Finelli,Yao-Hsuan Chen

DOI: https://doi.org/10.3390/tropicalmed8020075

2023-01-19

Tropical Medicine and Infectious Disease

Abstract:The COVID-19 pandemic has disrupted the seasonal patterns of several infectious diseases. Understanding when and where an outbreak may occur is vital for public health planning and response. We usually rely on well-functioning surveillance systems to monitor epidemic outbreaks. However, not all countries have a well-functioning surveillance system in place, or at least not for the pathogen in question. We utilized Google Trends search results for RSV-related keywords to identify outbreaks. We evaluated the strength of the Pearson correlation coefficient between clinical surveillance data and online search data and applied the Moving Epidemic Method (MEM) to identify country-specific epidemic thresholds. Additionally, we established pseudo-RSV surveillance systems, enabling internal stakeholders to obtain insights on the speed and risk of any emerging RSV outbreaks in countries with imprecise disease surveillance systems but with Google Trends data. Strong correlations between RSV clinical surveillance data and Google Trends search results from several countries were observed. In monitoring an upcoming RSV outbreak with MEM, data collected from both systems yielded similar estimates of country-specific epidemic thresholds, starting time, and duration. We demonstrate in this study the potential of monitoring disease outbreaks in real time and complement classical disease surveillance systems by leveraging online search data.
Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study

Antoine Brault,Isabelle Pontais,Vincent Enouf,Christine Debeuret,Emma Bloch,Juliette Paireau,Marie-Anne Rameix-Welti,Michael White,Gaëlle Baudemont,Bruno Lina,Isabelle Parent du Châtelet,Jean-Sébastien Casalegno,Sophie Vaux,Simon Cauchemez

DOI: https://doi.org/10.1016/S2352-4642(24)00143-3

Abstract:Background: Respiratory syncytial virus (RSV) is a major cause of hospitalisations and deaths among infants worldwide. France was one of the first countries to implement a national programme (beginning on Sept 15, 2023) for administration of nirsevimab, a single-dose long-acting monoclonal antibody treatment, to infants born on or after Feb 6, 2023, to prevent lower respiratory tract infection caused by RSV. We aimed to estimate the effectiveness of nirsevimab and the number of hospitalisations averted in children younger than 24 months in real-world settings. Methods: In this modelling study, we developed an age-structured deterministic model characterising RSV transmission as well as plausible scenarios for the administration of nirsevimab doses based on maternity ward and community pharmacy supply data. We retrospectively estimated nirsevimab effectiveness in infants younger than 24 months during the 2023-24 RSV season in France (excluding overseas territories) and the number of averted hospitalisations for RSV bronchiolitis occurring after emergency department visits, by calibrating the model to hospital and virological surveillance data from Aug 21, 2017, to Feb 4, 2024, alongside serological data from a previous cross-sectional study. To assess the robustness of our estimates, we conducted sensitivity analyses in which we modified our assumptions about the number of doses administered, the reconstruction of the number of RSV-associated hospitalisations for bronchiolitis, the duration of maternal and post-infection immunity to RSV, and the number of contacts in children aged 0-2 months. Findings: We estimated that nirsevimab administration prevented 5800 (95% credible interval 3700-7800) RSV-associated hospitalisations for bronchiolitis after emergency department visits among children younger than 24 months, including 4200 (2900-5600) hospitalisations among those aged 0-2 months, between Sept 15, 2023 (the date nirsevimab was introduced), and Feb 4, 2024-a 23% (16-30) reduction in the total number of hospitalisations and a 35% (25-44) reduction in the 0-2 months age group, compared with the scenario without administration. In our baseline scenario, in which we estimated that 215 000 doses of nirsevimab were administered by Jan 31, 2024, the estimated effectiveness against RSV-associated hospitalisations for bronchiolitis was 73% (61-84), corresponding to one hospitalisation averted for every 39 (26-54) doses administered. In sensitivity analyses, nirsevimab remained effective against RSV-associated hospitalisations for bronchiolitis after emergency department attendance. Interpretation: Our findings show that nirsevimab administration campaigns could effectively reduce the RSV-related hospital burden of bronchiolitis in children younger than 24 months. Funding: European Commission, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases programme, and INCEPTION project.
Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France

Alexandre Sabaté-Elabbadi,Lucie Brolon,Christian Brun-Buisson,Didier Guillemot,Muriel Fartoukh,Laurence Watier

DOI: https://doi.org/10.1016/j.jinf.2024.106287

Abstract:Objectives: We aimed to evaluate the impact of the pandemic and post-pandemic periods on hospital admissions for LRTI, with a focus on patients with chronic respiratory disease (CRD). Methods: From July 2013 to June 2023, monthly numbers of adult hospitalisations for LRTI (excluding SARS-CoV-2) were extracted from the French National Hospital Discharge Database. They were modelled by regressions with autocorrelated errors. Three periods were defined: (1) early pandemic and successive lockdowns; (2) gradual lifting of restrictions and widespread SARS-CoV-2 vaccination; (3) withdrawal of restriction measures. Results: Pre-pandemic incidence was 96 (90.5 to 101.5) per 100,000 population. Compared with the pre-pandemic period, no more seasonality and significant reductions were estimated in the first two periods: -43.64% (-50.11 to -37.17) and -32.97% (-39.88 to -26.05), respectively. A rebound with a positive trend and a seasonal pattern was observed in period 3. Similar results were observed for CRD patients with no significant difference with pre-pandemic levels in the last period (-9.21%; -20.9% to 1.67%), albeit with differential changes according to the type of CRD. Conclusions: COVID-19 pandemic containment measures contributed to changes in LRTI incidence, with a rapid increase and return to a seasonal pattern after their lifting, particularly in patients with CRD.
Respi-Radar, a tool to monitor respiratory infections in Belgium during the winter season 2023-2024

Geraldine De Muylder,Simon Couvreur,Giulietta Stefani,Claire Brugerolles,Yinthe Dockx,Milena Callies,Raphael Janssens,Laurane De Mot,Nathalie Bossuyt,Jorgen Stassijns

DOI: https://doi.org/10.1101/2024.11.13.24317167

2024-11-13

Abstract:Following the experience gathered during the COVID-19 crisis, the Respi-Radar was developed by the Belgian Risk Assessment Group (RAG) in the summer of 2023, with the aim of assessing the epidemiological situation of respiratory infections and informing public health preparedness and response in Belgium. The Respi-Radar consisted of four levels (green, yellow, orange and red) which indicated the extent of viral circulation and/or pressure on the healthcare system. Depending on the level, specific measures would apply to reverse the trend. The Respi-Radar used six indicators, from the Influenza-Like Illness and Severe Acute Respiratory Infection sentinel surveillances in nursing homes, primary and secondary care, as well as from the wastewater surveillance. Additional information, such as data from the national reference laboratories, also contributed to assessing the situation. Based on the Respi-Radar tool, the RAG regularly evaluated the epidemiological situation of respiratory infections between September 2023 and March 2024. The Respi-Radar tool appeared useful for following trends and effectively communicating on the epidemiological situation of respiratory infections. Applying specific measures depending on a level was less straightforward. The experience gained using the Respi-Radar tool was key to determine the best approach to assess and manage the epidemiological situation for future respiratory seasons.

Public and Global Health
[Mercury content of fishes in Finland].

V. Sjöblom,E. Häsänen

Abstract:
Surveillance of respiratory viruses by aerosol screening in indoor air as an early warning system for epidemics

Zeynep Bengi Eren,Cansel Vatansever,Berk Kabadayı,Bedirhan Haykar,Zeynep Ece Kuloğlu,Sedat Ay,Kamila Nurlybayeva,Gül Eyikudamacı,Tayfun Barlas,Erhan Palaoğlu,Yeşim Beşli,Mert Ahmet Kuşkucu,Önder Ergönül,Fusun Can

DOI: https://doi.org/10.1111/1758-2229.13303

Abstract:The development of effective methods for the surveillance of seasonal respiratory viruses is required for the timely management of outbreaks. We aimed to survey Influenza-A, Influenza-B, RSV-A, Rhinovirus and SARS-CoV-2 surveillance in a tertiary hospital and a campus over 5 months. The effectiveness of air screening as an early warning system for respiratory viruses was evaluated in correlation with respiratory tract panel test results. The overall viral positivity was higher on the campus than in the hospital (55.0% vs. 38.0%). Influenza A was the most prevalent pathogen in both locations. There were two influenza peaks (42nd and 49th weeks) in the hospital air, and a delayed peak was detected on campus in the 1st-week of January. Panel tests indicated a high rate of Influenza A in late December. RSV-A-positivity was higher on the campus than the hospital (21.6% vs. 7.4%). Moreover, we detected two RSV-A peaks in the campus air (48th and 51st weeks) but only one peak in the hospital and panel tests (week 49). Although rhinovirus was the most common pathogen in panel tests, rhinovirus positivity was low in air samples. The air screening for Influenza-B and SARS-Cov-2 revealed comparable positivity rates with panel tests. Air screening can be integrated into surveillance programs to support infection control programs for potential epidemics of respiratory virus infections except for rhinoviruses.
Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study

Alexis Rybak,Robert Cohen,Mathieu Bangert,Rolf Kramer,Jean-François Delobbe,Patrice Deberdt,Fabienne Cahn-Sellem,Stéphane Béchet,Corinne Levy

DOI: https://doi.org/10.1097/inf.0000000000004360

2024-04-10

Abstract:Objective: To assess the burden of respiratory syncytial virus (RSV)-related bronchiolitis in primary care and at 15 days and 6 months after a primary care visit. Study Design: In this test-negative study, children <2 years old with a first episode of bronchiolitis were prospectively enrolled by 45 ambulatory pediatricians in France from February 2021 to April 2023. RSV was assessed with a rapid antigen detection test. The burden of the disease was assessed with a questionnaire, including quality of life (PedsQL 1.0 Infant Scales), at 15-day and 6-month follow-up. Children with a positive RSV test result (RSV+) were compared to those with a negative test result (RSV−). Results: Among the 1591 children enrolled, 750 (47.1%) were RSV+. At 15 days follow-up (data availability: 69%), as compared with RSV− children, RSV+ children more frequently had fever (20.5% vs. 13.7%, P = 0.004) and decreased food intake (27.0% vs. 17.4%, P < 0.001) during the last 3 days. They had higher rates of hospitalization (11.8% vs. 5.8%, P < 0.001), childcare absenteeism (83.5% vs. 66.1%, P < 0.001) and parents who had to stop working to care for them (59.1% vs. 41.0%, P < 0.001) as well as lower quality of life (median PedsQL score 76.2 vs. 78.4, P = 0.03). At 6 months (data availability: 48.5%), the 2 groups did not differ in proportion of medical attendance, hospitalization, antibiotic treatment or quality of life. Conclusion: RSV+ children experienced much more severe disease and follow-up family and societal burden than RSV− children. These data may be used as baseline data as RSV prophylaxis is about to be implemented.

pediatrics,immunology,infectious diseases
Estimating the generation time for influenza transmission using household data in the United States

Louis Yat Hin Chan,Sinead E Morris,Melissa S Stockwell,Natalie M Bowman,Edwin Asturias,Suchitra Rao,Karen Lutrick,Katherine D Ellingson,Huong Q Nguyen,Yvonne Maldonado,Son H McLaren,Ellen Sano,Jessica E Biddle,Sarah E Smith-Jeffcoat,Matthew Biggerstaff,Melissa A Rolfes,H Keipp Talbot,Carlos G Grijalva,Rebecca K Borchering,Alexandra M Mellis,RVTN-Sentinel Study Group

DOI: https://doi.org/10.1101/2024.08.17.24312064

2024-08-19

MedRxiv

Abstract:The generation time, representing the interval between infections in primary and secondary cases, is essential for understanding and predicting the transmission dynamics of seasonal influenza, including the real-time effective reproduction number (Rt). However, comprehensive generation time estimates for seasonal influenza, especially post the 2009 influenza pandemic, are lacking. We estimated the generation time utilizing data from a 7-site case-ascertained household study in the United States over two influenza seasons, 2021/2022 and 2022/2023. More than 200 individuals who tested positive for influenza and their household contacts were enrolled within 7 days of the first illness in the household. All participants were prospectively followed for 10 days completing daily symptom diaries and collecting nasal swabs, which were tested for influenza via RT-PCR. We analyzed these data by modifying a previously published Bayesian data augmentation approach that imputes infection times of cases to obtain both intrinsic (assuming no susceptible depletion) and realized (observed within household) generation times. We assessed the robustness of the generation time estimate by varying the incubation period, and generated estimates of the proportion of transmission before symptomatic onset, infectious period, and latent period. We estimated a mean intrinsic generation time of 3.2 (95% credible interval, CrI: 2.9-3.6) days, with a realized household generation time of 2.8 (95% CrI: 2.7-3.0) days. The generation time exhibited limited sensitivity to incubation period variation. Estimates of the proportion of transmission that occurred before symptom onset, the infectious period, and the latent period were sensitive to variation in incubation periods. Our study contributes to the ongoing efforts to refine estimates of the generation time for influenza. Our estimates, derived from recent data following the COVID-19 pandemic, are consistent with previous pre-pandemic estimates, and will be incorporated into real-time Rt estimation efforts.
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study

Megan Bardsley,Roger A Morbey,Helen E Hughes,Charles R Beck,Conall H Watson,Hongxin Zhao,Joanna Ellis,Gillian E Smith,Alex J Elliot

DOI: https://doi.org/10.1016/s1473-3099(22)00525-4

IF: 71.421

2022-09-03

The Lancet Infectious Diseases

Abstract:Summary Background Seasonal epidemics of respiratory syncytial virus (RSV) cause a clinically significant burden of disease among young children. Non-pharmaceutical interventions targeted at SARS-CoV-2 have affected the activity of other respiratory pathogens. We describe changes in the epidemiology of RSV among children younger than 5 years in England since 2020. Methods Surveillance data on RSV infections, comprising laboratory-confirmed cases, proportion of positive tests, hospital admissions for RSV-attributable illness, and syndromic indicators for RSV-associated disease (emergency department attendances for acute bronchitis or bronchiolitis, non-emergency health advice telephone service [NHS 111] calls for cough, general practitioner [GP] in-hours consultations for respiratory tract infections, and GP out-of-hours contacts for acute bronchitis or bronchiolitis) were analysed from Dec 29, 2014 to March 13, 2022, for children younger than 5 years. Data were extracted from national laboratory, clinical, and syndromic surveillance systems. Time-series analyses using generalised linear models were used to estimate the effect of non-pharmaceutical interventions targeting SARS-CoV-2 on RSV indicators, with absolute and relative changes calculated by comparing observed and predicted values. Findings RSV-associated activity was reduced for all RSV indicators during winter 2020–21 in England, with 10 280 (relative change –99·5% [95% prediction interval –100·0 to –99·1]) fewer laboratory-confirmed cases, 22·2 (–99·6%) percentage points lower test positivity, 92 530 (–80·8% [–80·9 to –80·8]) fewer hospital admissions, 96 672 (–73·7% [–73·7 to –73·7]) fewer NHS 111 calls, 2924 (–88·8% [–90·4 to –87·2]) fewer out-of-hours GP contacts, 91 304 (–89·9% [–90·0 to –89·9]) in-hours GP consultations, and 27 486 (–85·3% [–85·4 to –85·2]) fewer emergency department attendances for children younger than 5 years compared with predicted values based on winter seasons before the COVID-19 pandemic. An unprecedented summer surge of RSV activity occurred in 2021, including 11 255 (1258·3% [1178·3 to 1345·8]) extra laboratory-confirmed cases, 11·6 percentage points (527·3%) higher test positivity, 7604 (10·7% [10·7 to 10·8]) additional hospital admissions, 84 425 (124·8% [124·7 to 124·9]) more calls to NHS 111, 409 (39·0% [36·6 to 41·8]) more out-of-hours GP contacts, and 9789 (84·9% [84·5 to 85·4]) more emergency department attendances compared with the predicted values, although there were 21 805 (–34·1% [–34·1 to –34·0]) fewer in-hours GP consultations than expected. Most indicators were also lower than expected in winter 2021–22, although to a lesser extent than in winter 2020–21. Interpretation The extraordinary absence of RSV during winter 2020–21 probably resulted in a cohort of young children without natural immunity to RSV, thereby raising the potential for increased RSV incidence, out-of-season activity, and health-service pressures when measures to restrict SARS-CoV-2 transmission were relaxed. Funding None.

medicine, general & internal

A Distributed Algorithm for Balanced Hypergraph Partitioning

Respiratory Syncytial Virus Seasonality, Beijing, China, 2007–2015

A semi-empirical risk panel to monitor epidemics: multi-faceted tool to assist healthcare and public health professionals

Evaluating a novel predictive tool for respiratory infection outbreaks in real life.

Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV

Integrating information from historical data into mechanistic models for influenza forecasting

Exploiting routinely collected severe case data to monitor and predict influenza outbreaks

Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April–June 2020)

Using a population-based Kalman estimator to model the COVID-19 epidemic in France: estimating associations between disease transmission and non-pharmaceutical interventions

Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018

Assessment of surveillance predictors for suspected respiratory syncytial virus, influenza and Streptococcus pneumoniae infections in children aged <5 years in Madagascar

Detecting signals of seasonal influenza severity through age dynamics

Real-Time Monitoring of Infectious Disease Outbreaks with a Combination of Google Trends Search Results and the Moving Epidemic Method: A Respiratory Syncytial Virus Case Study

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study

Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France

Respi-Radar, a tool to monitor respiratory infections in Belgium during the winter season 2023-2024

[Mercury content of fishes in Finland].

Surveillance of respiratory viruses by aerosol screening in indoor air as an early warning system for epidemics

Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study

Estimating the generation time for influenza transmission using household data in the United States

Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study